Biology of adeno-associated viral vectors in the central nervous system
- PMID: 25285067
- PMCID: PMC4168676
- DOI: 10.3389/fnmol.2014.00076
Biology of adeno-associated viral vectors in the central nervous system
Abstract
Gene therapy is a promising approach for treating a spectrum of neurological and neurodegenerative disorders by delivering corrective genes to the central nervous system (CNS). In particular, adeno-associated viruses (AAVs) have emerged as promising tools for clinical gene transfer in a broad range of genetic disorders with neurological manifestations. In the current review, we have attempted to bridge our understanding of the biology of different AAV strains with their transduction profiles, cellular tropisms, and transport mechanisms within the CNS. Continued efforts to dissect AAV-host interactions within the brain are likely to aid in the development of improved vectors for CNS-directed gene transfer applications in the clinic.
Keywords: adeno-associated virus (AAV); gene therapy; neurodegenerative diseases; neurological disorders; viral vectors.
References
-
- Arnett A. L., Beutler L. R., Quintana A., Allen J., Finn E., Palmiter R. D., et al. (2013). Heparin-binding correlates with increased efficiency of AAV1- and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction. Gene Ther. 20 497–503 10.1038/gt.2012.60 - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
